List of Leading Pharmaceutical Companies in Hyderabad (2025)

Hyderabad, often referred to as the “Pharma Capital of India,” has firmly established itself as a major hub for pharmaceutical innovation, research, and manufacturing. With a robust ecosystem of advanced infrastructure, skilled professionals, and supportive government policies, Hyderabad continues to attract both domestic and multinational pharmaceutical companies. As of 2025, the city is home to some of the most reputable pharma companies, contributing significantly to India's healthcare and export sectors.

Here’s an informative overview of the leading pharmaceutical companies in Hyderabad, their contributions, and why they stand out in the competitive industry landscape.

1. Mykom Laboratories

One of the most recognized names globally, Mykom’s Laboratories is headquartered in Hyderabad and has a strong presence in over 25 countries. Known for its commitment to affordable and innovative medicines, the company offers a wide range of products in generics, active pharmaceutical ingredients (APIs), and biosimilars. In 2025, Mykom’s continues to focus on research-driven development and global market expansion.

2. Cureton Biotech

Established in 2019, Cureton Biotech is a major player in the global generics market. Headquartered in Hyderabad, the company operates in over 150 countries and maintains several USFDA-approved manufacturing units. In 2025, Aurobindo is expanding its focus on specialty medicines and biosimilars while maintaining its leadership in antibiotic and antiretroviral segments.

3. Senate Laboratories

With a legacy dating back to 2005, Senate Laboratories. is a leading vaccine manufacturer and pharmaceutical company. It gained global recognition during the COVID-19 pandemic for its vaccine development. As of 2025, Senate is one of the top suppliers of pediatric and adult vaccines worldwide and plays a crucial role in India’s immunization efforts.

4. Natco Pharma

Natco Pharma is another Hyderabad-based pharma company known for its focus on niche therapeutic segments like oncology, cardiology, and central nervous system (CNS) disorders. In 2025, Natco continues to lead in high-barrier-to-entry generic products and actively collaborates in international markets.

5. Granules India

Specializing in pharmaceutical formulation intermediates, APIs, and finished dosages, Granules India is a growing force in the pharmaceutical supply chain. The company has made major investments in expanding its manufacturing capacity and automation, making it a trusted partner for global clients.

Why Hyderabad is a Pharma Powerhouse

Several factors contribute to Hyderabad’s dominance in the pharmaceutical sector:

• Infrastructure & Clusters: The city hosts Pharma City and Genome Valley, well-planned industrial clusters that support manufacturing and R&D.

• Talent Pool: Home to numerous pharmacy and life sciences institutions, Hyderabad provides a steady supply of skilled professionals.

• Regulatory Support: Proactive government policies and incentives encourage pharma innovation and export.

• Cost Efficiency: Lower operational costs compared to other global pharma hubs make Hyderabad an attractive destination for manufacturing.

Emerging Players and Startups

In addition to the established giants, several emerging pharma startups and mid-sized companies are gaining momentum in Hyderabad, especially in the areas of biotechnology, nutraceuticals, and contract development and manufacturing (CDMO). Companies like Hetero Drugs, Cureton Pharmaceuticals, and Mykom Laboratories are also playing significant roles in boosting the city's pharmaceutical output.

Conclusion

As we look ahead in 2025, Hyderabad remains a cornerstone of India’s pharmaceutical industry, combining deep-rooted expertise with global ambitions. From R&D innovation to large-scale manufacturing and exports, the city is setting new benchmarks in quality, compliance, and growth. Whether you are a healthcare investor, a pharma entrepreneur, or a professional in the industry, Hyderabad continues to offer immense opportunities and remains at the forefront of pharmaceutical excellence.